Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Legubicin vs doxorubicin in advanced soft tissue sarcoma
CTR20212527Phase 2Completed
- Sponsor
- Qinhe Bio
- Start
- Oct 2021
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of lecubicin in soft tissue sarcoma (STS), sponsored by Qinhe Bio. Started Oct 2021; status: completed.
02
Drugs
lecubicin
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on CTR20212527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212527.